디지털 치료제 시장 : 솔루션 유형별, 치료 유형별, 솔루션 목적별, 비즈니스 모델 유형별, 대상 치료 영역별, 주요 지역별 - 업계 동향과 세계 예측(-2035년)
Digital Therapeutics Market by Type of Solution, Type of Therapy, Purpose of Solution, Type of Business Model, Target Therapeutic Area and Key Geographical Regions : Industry Trends and Global Forecasts, Till 2035
상품코드:1648558
리서치사:Roots Analysis
발행일:2025년 01월
페이지 정보:영문 565 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 디지털 치료제 시장 규모는 2035년까지의 예측 기간 중 19.32%의 CAGR로 확대하며, 현재 28억 3,000만 달러에서 2035년까지 197억 6,000만 달러로 성장할 것으로 예측됩니다.
디지털 헬스는 세계 규모로 헬스케어를 개선하는 가장 유망한 어프로치의 하나입니다. 최근 디지털 치료제는 특히 만성질환이나 정신건강 문제 등 약리학적 개입으로 다루기 어려운 질환에 대해 여러 이해관계자들로부터 큰 관심을 받고 있습니다. 또한 디지털 헬스 솔루션의 활용을 촉진하기 위한 지속적인 노력과 함께 환자 중심의 기능 및 첨단 기술 접목이 이루어지고 있으며, 장기적으로 디지털 헬스 솔루션의 채택률이 크게 향상될 것으로 예상됩니다. 반면, 환자와 직원의 낮은 디지털 리터러시 수준은 여전히 큰 우려의 대상입니다. 디지털 헬스의 지속적인 발전과 함께 병원들은 이러한 디지털 솔루션을 도입하기 위해 직원들을 대상으로 인식 확산 및 디지털 솔루션 도입에 대한 세션을 제공하는 노력을 시작했습니다.
디지털 치료제의 인기가 높아지고 새로운 기술이 등장함에 따라 디지털 치료제 기업은 더 높은 채택을 보장하기 위해 첨단 기술을 각 포트폴리오에 통합하고 있습니다. 환자들의 인식이 높아지고 기존 수요를 충족시키기 위한 정부 및 업계 이해관계자들의 적극적인 노력에 힘입어 디지털 치료제 시장은 유리한 성장 기회를 목격할 것으로 예상됩니다.
현재 415개 이상의 디지털 치료제가 다양한 적응증에 대해 시판 중이거나 개발 중이고, 그 중 45개 이상% 독립형 소프트웨어 용도으로 제공되고 있습니다.
이 중 220개의 디지털·솔루션이 여성 건강에 초점을 맞추고 있으며, 약 30%가 생식 의료 관련 용도를 대상으로 하고 있습니다.
세계의 디지털 치료제 시장에 대해 조사했으며, 시장의 개요와 솔루션 유형별, 치료 유형별, 솔루션 목적별, 비즈니스 모델 유형별, 대상 치료 영역별, 주요 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.
목차
제1장 서문
제2장 개요
제3장 서론
제4장 현재 시장 구도
제5장 제품 경쟁력 분석
챕터 개요
전제/주요 파라미터
조사 방법
주요 치료 영역
제6장 기업 개요
챕터 개요
Akili Interactive
Big Health
dreem
Kaia Health
MindMaze
Omada Health
Pear Therapeutics
Vida Health
Voluntis
WellDoc
Wellthy Therapeutics
제7장 임상시험 분석
챕터 개요
범위와 조사 방법
디지털 치료제 : 임상시험 분석
임상 엔드포인트 분석
제8장 자금조달과 투자 분석
제9장 파트너십과 협업
챕터 개요
파트너십 모델
디지털 치료제 : 파트너십과 협업 리스트
제10장 시장 참여 전략
제11장 BOWMAN CLOCK의 가격 전략 분석
제12장 시장 예측
챕터 개요
예측 조사 방법과 주요 전제
2035년까지의 세계 디지털 치료 시장
디지털 치료 시장 : 2035년까지 솔루션 유형별 분석
디지털 치료 시장 : 2035년까지 솔루션 목적별 분석
디지털 치료 시장 : 2035년까지 치료 유형별 분석
디지털 치료 시장 : 2035년까지 비즈니스 모델별 분석
디지털 치료 시장 : 2035년까지 치료 영역별 분석
디지털 치료 시장 : 2035년까지 지역별 분석
결론
제13장 여성 디지털 헬스 : 새로운 개념의 출현
제14장 SWOT 분석
제15장 이그제큐티브 인사이트
제16장 결론
제17장 부록 1 : 표 형식 데이터
제18장 부록 2 : 기업·단체 리스트
KSA
영문 목차
영문목차
DIGITAL THERAPEUTICS MARKET: OVERVIEW
As per Roots Analysis, the global digital therapeutics market is estimated to grow from USD 2.83 billion in the current year to USD 19.76 billion by 2035, at a CAGR of 19.32% during the forecast period, till 2035.
The market sizing and opportunity analysis has been segmented across the following parameters:
Type of Solution
Software Solution
Gaming Solution
Combination Solution
Type of Therapy
Curative
Preventive
Purpose of Solution
Medication Replacement
Medication Augmentation
Type of Business Model
B2B
B2C
Therapeutic Area
Cardiovascular Disorders
Chronic Pain
Mental Health Problems
Metabolic Disorders
Neurological Disorders
Respiratory Disorders
Sleep Disorders
Substance Use Disorders
Other Disorders
Key Geographical Regions
North America
Europe
Asia
Latin America
Middle East and North Africa
Rest of the World
DIGITAL THERAPEUTICS MARKET: GROWTH AND TRENDS
Digital health is one of the most promising approaches to improving healthcare, at a global scale. In recent years, digital therapeutics have garnered significant interest from several stakeholders, especially for conditions that remain poorly addressed by pharmacological interventions, including chronic diseases and mental health issues. Moreover, given the ongoing efforts to promote the use of digital health solutions, along with the incorporation of patient centric features and advanced technologies, their adoption rates are anticipated to improve significantly in the long term. On the contrary, low digital literacy rates among patients and staff members are a major concern. With persistent advancements in digital health, hospitals have started taking initiatives to provide sessions to their staff members to spread awareness and implement such digital solutions.
Given the rising popularity of digital therapeutics and the emergence of several novel technologies, digital therapeutics companies are integrating advanced techniques to their respective portfolio to ensure higher adoptions. Driven by the growing awareness among patients and active efforts undertaken by the government, as well as industry stakeholders to meet the existing demand, the digital therapeutics market is expected to witness lucrative growth opportunities.
DIGITAL THERAPEUTICS MARKET: KEY INSIGHTS
The report delves into the current state of the digital therapeutics market and identifies potential growth opportunities within the industry. Some key findings from the report include:
At present, over 415 digital therapeutics are either commercially available or under development for various target indications; more than 45% of such solutions are offered as standalone software applications.
Amongst these, 220 digital solutions are focused on women's health; around 30% of such solutions target reproductive health related applications.
150+ developers are engaged in the development / evaluation of digital therapeutic solutions, targeting different age groups and a wide range of disease indications.
In pursuit of gaining a competitive edge, the digital therapeutic solution developers are focused on the integration of advanced features into their respective products and affiliated offerings.
More than 1.6 million patients have been recruited / enrolled across 500+ clinical trials registered for this novel class of therapies; nearly 40% of such studies are still actively recruiting patients.
To support the ongoing innovation in this field, several private and public investors have made substantial capital investments, amounting to over USD 8 billion, across ~370 instances.
Owing to the growing interest and lucrative opportunity associated with this domain, industry stakeholders are actively forging partnerships; ~20% of the deals have been focused on the commercialization of proprietary solutions.
In order to promote the adoption of their digital health solutions, developers are exploring various marketing strategies that highlight the key features of their products, across a number of platforms.
Given the rising incidence of chronic clinical conditions and the recent surge in demand for remote and digital health solutions, the market for digital therapeutics is anticipated to grow at a CAGR of ~20%, till 2035.
DIGITAL THERAPEUTICS MARKET: KEY SEGMENTS
Currently, Software Solutions Occupy the Largest Share of the Digital Therapeutics Market
Based on the type of solution, the market is segmented into software solution, gaming solution and combination solution. At present, the software solution segment holds the maximum share of the digital therapeutics market. This trend is unlikely to change in the near future.
Curative Solutions are Likely to Dominate the Digital Therapeutics Market During the Forecast Period
Based on the type of therapy, the market is segmented into curative and preventive solutions. At present, curative solution holds the maximum share within the digital therapeutics market. This trend is likely to remain the same in the forthcoming years.
Medication Replacement Solutions Segment is Likely to Dominate the Digital Therapeutics Market During the Forecast Period
Based on the purpose of solution, the market is segmented into medication replacement solutions and medical augmentation solutions. At present, medication replacement solution holds a larger share of the digital therapeutics market. This trend is likely to remain the same in the coming decade. It is worth highlighting that medical augmentation solution is likely to grow at a relatively higher CAGR.
Currently, B2B Model Occupies the Largest Share of the Digital Therapeutics Market
Based on the business model, the market is segmented into B2B and B2C. It is worth highlighting that majority of the current digital therapeutics market is captured by the B2B model.
Metabolic Disorders Account for the Largest Share of the Digital Therapeutics Market
Based on the target therapeutic area, the market is segmented into cardiovascular disorders, chronic pain, mental health problems, metabolic disorders, neurological disorders respiratory disorders, sleep disorders, substance use disorders and other disorders. While metabolic disorders account for a relatively higher market share, it is worth highlighting that the neurological disorders segment is expected to witness substantial market growth in the coming years.
North America Accounts for the Largest Share of the Market
Based on key geographical regions, the market is segmented into North America, Europe, Asia, Middle East and North Africa, Latin America, and the Rest of the world. The majority share is expected to be captured by developers based in North America. It is worth highlighting that, over the years, the market in Asia is expected to grow at a higher CAGR.
Example Players in the Digital Therapeutics Market
Ampersand Health
Akili Interactives
Better Therapeutics
Brain+
Click Therapeutics
CogniFit
GAIA
Healios
JOGO Health
Jolly Good
KORE Digital Health Therapeutics
Livongo Health
Lucid
MedRhythms
Pear Therapeutics
Redicare Control
Susmed
The Learning Corp
Voluntis
WellDoc
Primary Research Overview
The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:
Chief of Staffs to CEO and Strategy Lead, Ampersand Health
Ex-Chief Executive Officer, Canary Health
Marketing Director, Dnurse Technology
Chief Strategy Officer, EMBR Labs
Founder and Chief Executive Officer, Exosystems
Chief Executive Officer, Floreo
Chief Commercial Officer, GAIA
Chairman and Chief Executive Officer, Healios
Co-Founder and President, Joggo Health
Chief Executive Officer, metaMe Health
Chief Executive Officer, SelfBack
Ex-Chief Executive Officer, Somatix
Chief Executive Officer, Tilak Healthcare
Chief Executive Officer, Turnaround Health
Co-Founder and Chief Executive Officer, Vida Health
Ex-Communication Manager, Voluntis
Ex-Vice President Marketing, Ex-Senior Manager Consumer Marketing, and Ex-Marketing and Public Relations, Wellthy Therapeutics
Founder and Chief Executive Officer, Undisclosed
DIGITAL THERAPEUTICS MARKET: RESEARCH COVERAGE
Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the digital therapeutics market, focusing on key market segments, including [A] type of solution, [B] type of therapy, [C] purpose of solution, [D] type of business model, [E] target therapeutic area and [F] key geographical regions.
Market Landscape: A comprehensive evaluation of digital therapeutics solutions, considering various parameters, such as [A] status of development, [B] type of solution, [C] type of therapy, [D] purpose of solution, [E] target indication(s), [F] therapeutic area and [G] target population. Additionally, it includes information related to digital therapeutics solution developers, highlighting their [H] year of establishment, [I] company size, [J] type of business model and [K] location of their headquarters.
Product Competitiveness Analysis: A comprehensive competitive analysis of digital therapeutics solutions, examining factors, such as [A] product portfolio (based on the number of digital therapeutic solutions being developed for that therapeutic area) and [B] key product specific parameters (such as status of development, type of solution, type of therapy, prescription requirement and purpose of solution).
Company Profiles: In-depth profiles of key industry players that are either offering or engaged in the development of digital therapeutics solutions, focusing on [A] company overviews, [B] product portfolio, [C] recent developments and [D] an informed future outlook.
Clinical Trials Analysis: Examination of completed, ongoing, and planned clinical studies of various digital therapeutics, based on parameters like [A] trial registration year, [B] trial phase, [C] number of patients enrolled, [D] study design, [E] trial recruitment status and trial focus, [F] type of organization, [G] regional distribution of trials and [H] an insightful clinical end-points analysis (for top ten recent initiated trials for popular therapeutic areas).
Funding and Investment Analysis: A detailed evaluation of the investments made in the digital therapeutics' market, encompassing grants, debt financing, seed funding, venture series, initial public offering, secondary offerings, private placements and other equity.
Partnerships and Collaborations: An analysis of partnerships established in this sector, since 2016, covering marketing and distribution agreements, mergers / acquisitions, pilot product offerings, product / technology integration agreements, product / technology licensing agreements, product development agreements, product evaluation agreements, product training agreements, product development agreements, research and development agreements, and commercialization agreements.
Go-To-Market Strategy: A detailed analysis of various business models and go-to-market strategies adopted by firms engaged in developing digital therapeutics solutions, highlighting details on various channels adopted by the stakeholders in order to raise awareness and offer access to their proprietary products.
Bowman's Clock Pricing Strategy: A Bowman's clock pricing strategy framework evaluates the competitive position of various companies within this sector by examining their product prices and features. Additionally, it introduces an equation designed to estimate the potential price of digital therapeutics based on their attributes.
KEY QUESTIONS ANSWERED IN THIS REPORT
How many companies are currently engaged in this market?
Which are the leading companies in this market?
What kind of partnership models are commonly adopted by industry stakeholders?
What factors are likely to influence the evolution of this market?
What is the current and future market size?
What is the CAGR of this market?
How is the current and future market opportunity likely to be distributed across key market segments?
REASONS TO BUY THIS REPORT
The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
ADDITIONAL BENEFITS
Complimentary PPT Insights Packs
Complimentary Excel Data Packs for all Analytical Modules in the Report
10% Free Content Customization
Detailed Report Walkthrough Session with Research Team
Free Updated report if the report is 6-12 months old or older
TABLE OF CONTENTS
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1 Chapter Overview
3.2. Digitization in the Healthcare Sector
3.3. Next-Generation Healthcare Solutions
3.4. Key Concepts Associated with Digital Health Solutions
3.4.1. Cognitive Behavioral Therapy (CBT)
3.4.2. Internet of Things (IoT)
3.4.3. Big Data
3.4.4. Artificial Intelligence (AI)
3.4.5. Gamification
3.5. Overview of Digital Therapeutics
3.5.1. Key Strategic Initiatives
3.5.1.1. Digital Therapeutics Alliance (DTA)
3.5.1.2. Personal Connected Health (PCH) Alliance
3.5.1.3. Programs Initiated by The Centers for Disease Control and Prevention (CDC)
3.5.1.4. Health Insurance Portability and Accountability Act (HIPAA)
3.5.1.5. National Health Service (NHS) Guidelines
3.5.1.6. United States Food and Drug Administration (USFDA) Regulations for Digital Therapeutics
3.5.2. Typical Development and Commercialization Path for Digital Therapeutics
